Predictive Model for PENS Response in Subacromial Pain Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNéstor Requejo Salinas
About this trial
Subacromial pain syndrome (SPS) is one of the most common causes of shoulder pain, leading to significant disability and socioeconomic burden. Although percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve (SN) has shown positive therapeutic outcomes, individual response to the intervention varies considerably. This study aims to develop a multivariable predictive model to estimate clinical response to SN-targeted PENS in patients with SPS. The model will be built using clinical, psychological, and neural mechanosensitivity variables. The goal is to enhance patient selection and guide personalized treatment strategies.
Eligibility criteria
Qualifiers
Pain localized to the anterolateral shoulder region.
Symptoms present for more than 6 weeks.
Painful arc during shoulder abduction.
Positive Neer or Hawkins-Kennedy impingement signs.
Disqualifiers
Bilateral shoulder pain.
History of fracture, dislocation, or surgical intervention on the affected shoulder.
Presence of other shoulder pathologies such as adhesive capsulitis (frozen shoulder), glenohumeral instability, or full-thickness rotator cuff tear.
Medical contraindications for PENS application (e.g., active anticoagulation, pregnancy, or decompensated psychiatric condition).
Trial design
Treatments tested in this trial
- Percutaneous Electrical Nerve Stimulation (PENS)
Treatment groups
269 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Néstor Requejo Salinas
Lead sponsor
Centro Universitario La Salle
Sponsor institution
University of Alcala
Collaborator
Centro Universitario La Salle
Collaborator
Source ClinicalTrials.gov